Drugs / Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5
Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01644565 | Aug 2012 → Jun 2014 | escherichia coli infection | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01644565 ↗ |
| Modality | Protein / enzyme biologic | “chimeric E. coli protein” NCT01644565 ↗ |